SecBot SecBot
Institutional Cluster

BMY

BRISTOL MYERS SQUIBB CO
BULLISH
Impact 6/10
Horizonweeks Processed3mo ago
Institutional cluster: 20 buyers, 8 sellers (bullish)
Actionable Insight ▲ Bullish

A powerful institutional cluster formed in BMY during Q2 2026, with 20 buyers accumulating $2.46B net against 8 sellers reducing by $680M. The buying is dominated by Norges Bank's massive $2.12B new position, alongside significant adds from Fidelity and T. Rowe Price, while Dodge & Cox and Capital International were notable sellers. This cluster aligns with the company's strong Q2 earnings beat and raised guidance reported 18 days prior, suggesting institutions are positioning for sustained Growth Portfolio momentum and upward earnings revisions. The absence of insider buying weakens the conviction slightly, but the scale and breadth of institutional accumulation is a strong bullish signal for the pharmaceutical giant's turnaround story.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$64.63
T+0 close · Aug 17, 2026 · via day close
Latest settled
−2.83%
T+60 · $62.80
Vs SPY
+0.11%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 17 $64.63entry
  2. T+1 · 3mo ago +2.20%α +2.87% · $66.05
  3. T+5 · 3mo ago +4.10%α +5.29% · $67.28
  4. T+20 · 2mo ago −1.39%α +0.58% · $63.73
  5. T+60 · 7d ago −2.83%α +0.11% · $62.80

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A powerful institutional cluster formed in BMY during Q2 2026, with 20 buyers accumulating $2.46B net against 8 sellers reducing by $680M. The buying is dominated by Norges Bank's massive $2.12B new position, alongside significant adds from Fidelity and T. Rowe Price, while Dodge & Cox and Capital International were notable sellers. This cluster aligns with the company's strong Q2 earnings beat and raised guidance reported 18 days prior, suggesting institutions are positioning for sustained Growth Portfolio momentum and upward earnings revisions. The absence of insider buying weakens the conviction slightly, but the scale and breadth of institutional accumulation is a strong bullish signal for the pharmaceutical giant's turnaround story.

Key Financial Metrics

Direction
accumulating
Buy Value
$3.1B
Sell Value
$680.5M
Net Flow
$2.5B

Institutional Positions

Net institutional flow: $2.5B

▲ Buyers (20)

InstitutionActionChangePosition ValueValue Δ
Norges BankNEWNot reported$2.1B$2.1B
FidelityADD+52.7%$938.8M$291.6M
T. Rowe PriceDOUBLED+209.3%$1.8M$1.2M

▼ Sellers (8)

InstitutionActionChangePrev ValueValue Δ
Dodge & CoxNEAR_EXIT-99.1%$280.4M-$277.9M
Capital International InvestorsTRIM-29.9%$511.2M-$170.4M
Renaissance TechnologiesEXIT-100%$59.3M-$59.3M

Key Facts

  • 20 institutional buyers vs 8 sellers in Q2 2026
  • Net institutional accumulation of $2.46B
  • Norges Bank initiated a $2.12B new position (36.87M shares)
  • Fidelity added $291.6M (+52.7% position increase)
  • T. Rowe Price doubled its position (+209.3%)
  • Dodge & Cox nearly exited ($277.9M sold, -99.1%)
  • Renaissance Technologies and Bridgewater fully exited
  • Cluster follows Q2 2026 earnings beat (EPS $2.04 vs $1.60 est) and raised full-year guidance
  • No open-market insider buying during the window (institutions-only signal)

Financial Impact

Net institutional buying of $2.46B across 20 funds, with total buying value of $3.15B and total selling value of $680M

institutional ownershipfloatvaluation

Risk Factors

  • No insider buying to corroborate the institutional thesis
  • Dodge & Cox's near-exit and Capital International's trim suggest some long-term holders are skeptical
  • 13F data is 45+ days stale; positions may have been adjusted since quarter-end

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
40% bullish (35 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-BMY-2026-Q2

Track record

9 reports on BMY

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 6, 202610d ago 144 Neutral 2/10 Entry $62.14 to $62.14 · 0.00% −2.37% vs SPY
  2. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $61.39 to $62.48 ▲ +1.78% +3.55% vs SPY
  3. Oct 23, 202624d ago Institutional Cluster Neutral 3/10 Entry $61.48 to $61.61 ▲ +0.21% −0.50% vs SPY
  4. Oct 5, 20266w ago ANALYST-DOWNGRADE Bearish 4/10 No price data
  5. Aug 17, 202613w ago Institutional Cluster Bullish 6/10 Viewing Entry $64.63 to $66.05 ▲ +2.20% +2.87% vs SPY
  6. Aug 5, 202614w ago ANALYST-UPGRADE Bullish 4/10 Entry $63.63 to $64.15 ▲ +0.82% +0.98% vs SPY
  7. Jul 30, 202615w ago 8-K Bullish 7/10 Entry $64.86 to $65.31 ▲ +0.69% −0.01% vs SPY
  8. Mar 25, 202633w ago DEFA14A Neutral 3/10 Entry $59.39 to $58.47 ▼ −1.55% +0.13% vs SPY
  9. Feb 26, 202637w ago Court Ruling Neutral 3/10 Entry $62.37 to $62.34 ▼ −0.05% −0.10% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens Wed (9h 31m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 17, 2026